Hans Edgar Bishop Insider Profile

11 Followers
Hans Edgar Bishop, CEO & President, Director at Juno Therapeutics, holds 5.79M shares in Sana Biotechnology (Ticker: SANA), holds 24.98K shares in Agilent (Ticker: A), holds 4.69M shares in Lyell Immunopharma (Ticker: LYEL).
tipranks
Hans Edgar Bishop

Hans Edgar Bishop
Juno Therapeutics (JUNO)
CEO & President, Director

Not Ranked
Hans Edgar Bishop has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$30M
70.98%
17.58%
11.45%
A breakdown of Hans Edgar Bishop's holdings

Insider Roles

Sana Biotechnology
(SANA)
Director
Lyell Immunopharma
(LYEL)
Director
Agilent
(A)
Director
Roles that Hans Edgar Bishop holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Hans Edgar Bishop

Hans Edgar Bishop's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
JUNO
Juno Therapeutics
Mar 07, 2018
Uninformative Sell
201.21M
$0.00
Agilent
Mar 19, 2024
Director
Uninformative Buy
358.08K
$3.42M
CELG
Celgene
Nov 22, 2019
Uninformative Sell
$0.00
Lyell Immunopharma
Sep 09, 2022
Director
Uninformative Buy
14.54K
$5.25M
Sana Biotechnology
Oct 09, 2024
Director
Uninformative Buy
$21.19M
DNDNQ
Dendreon Corp
Aug 02, 2011
Uninformative Sell
86.26K
AVNR
Avanir Pharmaceuticals
Feb 14, 2014
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Hans Edgar Bishop's performance on stock

Hans Edgar Bishop insider profile FAQ

What is the percentage of profitable transactions made by Hans Edgar Bishop?
The percentage of profitable transactions made by Hans Edgar Bishop is ―.
    What is the average return per transaction made by Hans Edgar Bishop?
    The average return per transaction made by Hans Edgar Bishop is ―.
      What stocks does Hans Edgar Bishop hold?
      Hans Edgar Bishop holds: JUNO, A, CELG, LYEL, SANA, DNDNQ, AVNR stocks.
        What was Hans Edgar Bishop’s latest transaction?
        Hans Edgar Bishop latest transaction was an Uninformative Buy of ―.
          What was Hans Edgar Bishop's most profitable transaction?
          Hans Edgar Bishop’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Hans Edgar Bishop's role in Juno Therapeutics?
            Hans Edgar Bishop's role in Juno Therapeutics is CEO & President, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.